Igc PharmaIGC
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 36 institutions reported holding Igc Pharma Inc. (IGC) in their 13F filings, up 1 from Q1 2026. 6 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($239K), Vanguard Capital Management LLC ($222K) and BlackRock, Inc. ($191K). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Fisher (0.0% of Fisher Asset Management's portfolio).
- Company
- Igc Pharma Inc.
- CUSIP
- 45408X308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $334K |
| Exits | 4 | $17K |
All 13F filers, Q1 2026 → Q2 2026: 1,401,679 shares bought and 539,331 shares sold, net +862,348 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 36 holders
| Geode Capital Management, LLC | 0.00% | Reduce -15.7% | 879,394 | $239K |
| Vanguard Capital Management LLC | 0.00% | Add +13.4% | 814,914 | $222K |
| BlackRock, Inc. | 0.00% | No change | 703,798 | $191K |
| AdvisorShares Investments LLC | 0.02% | New | 678,480 | $185K |
| Citadel Advisors | 0.00% | New | 437,317 | $119K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.8% | 419,413 | $114K |
| Renaissance Technologies | 0.00% | Reduce -40.8% | 286,608 | $78K |
| State Street Corp. | 0.00% | No change | 200,799 | $55K |
| Northern Trust Corp. | 0.00% | Add +50.1% | 170,274 | $46K |
| Lawood & Co. | 0.01% | No change | 75,000 | $20K |
| Goldman Sachs Group Inc. | 0.00% | No change | 65,541 | $18K |
| Jane Street Group, LLC | 0.00% | New | 62,610 | $17K |
| Dearborn Partners LLC | 0.00% | No change | 59,401 | $16K |
| Truist Financial Corp. | 0.00% | Add +32.7% | 48,667 | $13K |
| Citigroup Inc. | 0.00% | New | 46,043 | $13K |
| Fisher Asset Management | 0.00% | No change | 43,400 | $12K |
| XTX Topco Ltd | 0.00% | Reduce -22.3% | 39,378 | $11K |
| Morgan Stanley | 0.00% | Add +0.2% | 35,198 | $10K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -1.5% | 33,348 | $9K |
| Susquehanna International Group, LLP | 0.00% | Reduce -76.4% | 28,882 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +31.2% | 27,607 | $8K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 14,944 | $4K |
| Wealthcare Advisory Partners LLC | 0.00% | No change | 10,000 | $3K |
| Burnham & Co LLC | 0.00% | — | 5,000 | $1K |
| Geneos Wealth Management Inc. | 0.00% | No change | 3,000 | $810 |
| Group One Trading LLC | 0.00% | Reduce -30.9% | 2,600 | $707 |
| Rockefeller Capital Management L.P. | 0.00% | New | 1,000 | $272 |
| Barclays PLC | 0.00% | New | 721 | $196 |
| Caitlin John, LLC | 0.00% | No change | 200 | $54 |
| Hurley Capital, LLC | 0.00% | No change | 100 | $27 |
| Farther Finance Advisors, LLC | 0.00% | No change | 101 | $27 |
| DHJJ Financial Advisors, Ltd. | 0.00% | No change | 80 | $22 |
| Napier Financial, LLC | 0.00% | No change | 58 | $16 |
| Johnson Financial Group, Inc. | 0.00% | No change | 1 | $1 |
| Triumph Capital Management | 0.00% | No change | 2 | $1 |
| UBS Group AG | 0.00% | Reduce -100.0% | 1 | $0 |
"% of holder's portfolio" is IGC's weight in each manager's 13F, not the share of Igc Pharma Inc. the manager owns.